Cordlife Group (P8A) AI Stock Analysis

• Market Cap: S$36.51M
• Dividend Yield: N/A
• Average Volume (3M): 14.19K
• Price to Earnings (P/E): ―
• Beta (1Y): 0.32
• Revenue Growth: 2.83%
• EPS Growth: -0.71%
• Country: SG
• Employees: 596
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Diagnostics & Research
• EPS (TTM): -0.02
• Shares Outstanding: 267,525,360
• 10 Day Avg. Volume: 3,230
• 30 Day Avg. Volume: 14,193
• PEG Ratio: <0.01
• Price to Book (P/B): 0.33
• Price to Sales (P/S): 1.38
• P/FCF Ratio: -2.46
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 49 Neutral
• Price Target: S$0.16 ▲(21.54% Upside)
• Action: Reiterated Date: 01/15/26
• Date: Action: Reiterated 01/15/26

The score is held down mainly by weak profitability and cash flow (negative margins and negative operating cash flow), despite strong revenue growth and a low-leverage balance sheet. Technicals show short-term price strength but with overbought signals and a weaker longer-term trend. Valuation support is limited because the company is loss-making (negative P/E) and no dividend yield is available.

Positive Factors

Revenue Growth

Sustained ~17% TTM revenue growth demonstrates expanding market adoption of cord banking services across Asia. Over a 2–6 month horizon this growth supports higher lifetime customer value from annual storage fees, helps absorb fixed costs, and underpins scaling of processing capacity.

Negative Factors

Poor Profitability

Deep negative EBIT and net margins indicate core operating losses despite revenue growth. Persisting at current levels, these margins will erode equity, limit reinvestment capacity, and require substantial cost reductions or higher-margin service mix to achieve sustainable profitability over the medium term.

Cordlife Group Business Overview & Revenue Model

Company Description

Cordlife Group Limited, an investment holding company, provides cord blood banking services in Singapore, Hong Kong, India, Malaysia, the Philippines, and internationally. It operates in two segments, Banking and Diagnostics. The Banking segment c...

Read more

Cordlife Group Limited, an investment holding company, provides cord blood banking services in Singapore, Hong Kong, India, Malaysia, the Philippines, and internationally. It operates in two segments, Banking and Diagnostics. The Banking segment c...

How the Company Makes Money

Cordlife generates revenue primarily through its cord blood and cord tissue banking services, which involve one-time collection and processing fees followed by annual storage fees. The company charges parents for the initial collection and process...

Read more

Cordlife generates revenue primarily through its cord blood and cord tissue banking services, which involve one-time collection and processing fees followed by annual storage fees. The company charges parents for the initial collection and process...

Cordlife Group Financial Statement Overview

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	28.62M	27.84M	55.73M	55.16M	56.67M	44.66M
Gross Profit	16.03M	11.73M	37.30M	37.19M	39.48M	30.37M
EBITDA	-8.06M	-14.38M	8.56M	9.34M	10.78M	4.85M
Net Income	-8.45M	-18.69M	3.52M	4.89M	6.13M	4.96M
Balance Sheet
Total Assets	207.39M	217.14M	228.46M	228.00M	233.71M	176.58M
Cash, Cash Equivalents and Short-Term Investments	51.98M	60.58M	65.01M	65.17M	64.63M	71.96M
Total Debt	1.06M	2.42M	3.50M	2.22M	2.97M	5.79M
Total Liabilities	95.53M	98.68M	92.81M	93.67M	97.02M	75.71M
Stockholders Equity	111.61M	118.21M	135.33M	134.06M	136.43M	100.77M
Cash Flow
Free Cash Flow	-7.39M	-15.62M	6.96M	5.32M	7.93M	11.17M
Operating Cash Flow	-4.58M	-11.31M	9.80M	7.71M	9.50M	12.04M
Investing Cash Flow	-5.46M	-2.81M	-2.63M	4.43M	-23.91M	-1.01M
Financing Cash Flow	5.34M	7.17M	-1.86M	-13.45M	3.37M	-2.16M

Cordlife Group Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 0.13
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SG:P8A, the sentiment is Positive. The current price of 0.13 is below the 20-day moving average (MA) of 0.13, below the 50-day MA of 0.14, and below the 200-day MA of 0.18, indicating a neutral trend. The MACD of <0.01 indicates Negative momentum. The RSI at 57.79 is Neutral, neither overbought nor oversold. The STOCH value of 77.03 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for SG:P8A.

Cordlife Group Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
BSL	68 Neutral	S$1.92B	26.74	6.15%	2.45%	8.90%	4.57%
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
P8A	49 Neutral	S$36.51M	-10.60	-8.35%	―	2.83%	-0.71%
A50	46 Neutral	S$1.48B	-23.90	-9.69%	―	12.39%	-400.00%